Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research on Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Carrer De Natzaret, 115, Barcelona,catalonia 08035,spain
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.peptomyc.com
- Keywords
- Oncology, Myc, Glioblastoma, NSCLC, Breast cancer, VHIO.
- HQ
- Barcelona, Catalonia
Peptomyc Questions
Peptomyc's website is http://www.peptomyc.com
Peptomyc's LinkedIn profile is https://es.linkedin.com/company/peptomyc
Peptomyc has
21 employees.
View email and phone details for 21
employees at Peptomyc.
Peptomyc's industry is
Research Services
Peptomyc's top competitors are
Ona Therapeutics,
Splicebio,
Aptadel Therapeutics,
Mimark Diagnostics,
Aelix Therapeutics,
Nuage Therapeutics,
Oryzon Genomics Sa,
Minoryx Therapeutics,
Oxolife,
Highlight Therapeutics Sl.
Peptomyc's categories are Research Services
Peptomyc's founding year is 2014
